B7-H3-Targeted Antibody-Drug Conjugates | Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
Research To Practice | Oncology Videos · Dr. Neil Love
April 4, 20241h 14m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Dr Manish Patel, including the following topics:
- Insights into a comprehensive clinical research practice (0:00)
- Transformation of the conduct and design of clinical trials (3:41)
- Disparities and conundrums in clinical trial recruitment (10:11)
- Rationale of clinical trial dosing and regulatory initiatives (15:37)
- Innovation and advancements in oncology research and clinical development (18:47)
- Practical considerations into patient care during a clinical trial (20:52)
- Encouraging physicians to participate in oncology research (24:29)
- Pharmacology of B7-H3 and role in tumor pathogenesis (31:56)
- Current and future clinical development of ifinatamab deruxtecan (I-DXd) (34:11)
- Available clinical data with vobramitamab duocarmazine across numerous solid tumors (1:02:44)
- Early clinical data with HS-20093 for advanced solid tumors (1:06:36)
CME information and select publications